WEINAS PD-160 IV Compounding Robot

Developed by Weibond Technology, the WEINAS PD-160 series represents the world’s first IV compounding robot capable of handling both vial and ampoule drug containers. This dual compatibility addresses the specific needs of Chinese hospital pharmacies, where both container formats remain widely used for injectable medications.

Product Overview

The WEINAS PD-160 (Weibond Intravenous Assistant System) is a fully automated robotic system designed for sterile IV drug preparation in hospital pharmacy settings. Launched commercially in 2016, the system automates the complex process of transferring medications from vials and ampoules into IV bags or syringes while maintaining aseptic conditions.

The PD-160 distinguishes itself from competing systems through its patented ability to process both vial and ampoule containers within a single platform. Most IV compounding robots on the global market handle only vials, requiring manual preparation for ampoule-based medications.

Key Features

Deployed in Chinese hospitals since 2016, WEINAS PD-160 handles both vials and ampoules—a dual compatibility no other IV compounding robot on the global market offers.

• Dual Container Compatibility: Processes both vials and ampoules automatically, eliminating the need for separate manual preparation workflows
• ISO Class 5 Environment: HEPA-certified air filtration system maintains continuous sterile conditions throughout compounding
• Image Recognition Verification: Visual identification system confirms drug identity before compounding begins
• Barcode Scanning: Verifies order information and ingredient matching at multiple process steps
• Patented Liquid Transfer: Proprietary transfer mechanism minimizes particulate contamination risk
• Video Recording: Multiple cameras document the entire preparation process for quality assurance
• Gravimetric Control: Precision weighing verifies dose accuracy during preparation

Technical Specifications

Deployed since 2016, WEINAS PD-160 supports individual patient-specific and batch compounding modes within an ISO Class 5 sterile environment.

Clinical Applications

The WEINAS PD-160 is deployed for various IV compounding applications:

Hazardous Drug Preparation

• Chemotherapy compounding for oncology
• Cytotoxic drug preparation
• High-risk medication handling

General IV Compounding

• Total parenteral nutrition (TPN)
• Antibiotic admixtures
• Pain management infusions
• Critical care medications

Research published in peer-reviewed journals demonstrates the system’s effectiveness in reducing environmental contamination. A study comparing WEINAS robotic compounding to manual preparation in biological safety cabinets found surface contamination on infusion bags was 9 times lower for cyclophosphamide and 23 times lower for gemcitabine when using the robotic system.

Regulatory Status

The WEINAS PD-160 has been in clinical use in Chinese hospitals since 2016. International regulatory status outside China has not been publicly confirmed.

Frequently Asked Questions

What drug containers can the WEINAS PD-160 process?

The PD-160 is the only IV compounding robot on the market that handles both vials and ampoules. This dual compatibility is particularly relevant for Asian markets where ampoule-based medications remain common.

How does the PD-160 ensure dose accuracy?

The system uses multiple verification methods: barcode scanning confirms drug identity, image recognition verifies container type and fill level, and gravimetric measurement confirms final dose weight within acceptable tolerances.

Which hospitals use the WEINAS PD-160?

Documented deployments include Shanghai Jiaotong University School of Medicine Renji Hospital and Sichuan Provincial People’s Hospital, among other major Chinese tertiary hospitals.